Analytical Data
-
Gene name
Ren2
- Application
-
Alternative Names
ChemerinRAR-responsive protein TIG2Tazarotene-induced gene 2 protein
-
Species
Mouse
-
Source
E. coli
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P00796
-
Expression Region
64-351aa
-
Molecular Weight
35 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Ren2, a recombinant protein derived from the Renin-angiotensin system, plays a crucial role in regulating blood pressure, electrolyte balance, and overall cardiovascular health. It is primarily produced in the kidneys, where it catalyzes the conversion of angiotensinogen to angiotensin I, subsequently leading to the formation of angiotensin II, a potent vasoconstrictor. Research on Ren2 has gained attention due to its potential implications in hypertension and heart disease. As hypertension remains a leading health concern globally, understanding the molecular mechanisms and pathways involving Ren2 is essential for developing targeted therapies. Recombinant versions of Ren2 are utilized in experimental settings to elucidate its biological functions, investigate its interactions with various receptors, and explore its effects in vivo. Furthermore, studies have shown that modulation of Ren2 activity may offer new avenues for treating conditions like diabetic nephropathy, heart failure, and other cardiovascular disorders. Advances in genetic engineering and protein expression systems have facilitated the production of high-purity Ren2, enabling detailed biochemical and pharmacological studies. By unraveling the complexities of Ren2 and its role in cardiovascular physiology, researchers aim to contribute to innovative therapeutic strategies that address the pressing challenges of cardiovascular diseases.
